Featured
Optical Coherence Tomography Angiography for Glaucoma Diagnosis and Follow-Up
Essential to practice or still a research tool?
By Kevin Gillmann, MD, MBBS, FEBOphth, MArch, Kaweh Mansouri, MD, MPH
Four Reasons to Consider Electrophysiologic Testing
In conjunction with clinical exams, this test can provide insights that better direct glaucoma treatment.
By Mark A. Latina, MD
Glaucoma Screening in 2018
The when, why, how, and who of screening for glaucoma.
By STEVEN MANSBERGER, MD, David S. Sanders, MD, MPH
Choosing a Winner for You and Your Surgical Patient
Considerations for learning and incorporating MIGS.
By E. Randy Craven, MD, Jithin Yohannan, MD, MPH, Aakriti Garg, MD, et al.
Departments
From the Editor: Today's MIGS Landscape
The FDA and industry collaborate to ensure safety.
By Nathan M. Radcliffe, MD
Coding: Reimbursement for Managing Complications of Glaucoma Surgery
By Kevin J. Corcoran, COE, CPC, CPMA, FNAO
Glaucoma Myth Busters: Myths About Endoscopic Cyclophotocoagulation
A MIGS procedure with an excellent safety profile.
By Steven R. Sarkisian, Jr., MD
Patients Are Asking: What Should My Eye Pressure Be?
The answer is not as simple as you might think.
By Brandon Baartman, MD, JOHN BERDAHL, MD
Product Spotlight: Microstent Uses Three-Prong Approach to Lower IOP
The rigorously studied device has impressive efficacy and safety records.
By Karen Appold, contributing writer
Web Exclusives
FDA Approves Hydrus MIGS Device
By Jerry Helzner, contributing editor
FDA Clears IOP Measuring Device
By Jerry Helzner, contributing editor
Santen Begins Phase 3 Trials for Glaucoma Agonist
By Jerry Helzner, contributing editor
Nidek Launches New Type of Gonioscope
By Jerry Helzner, contributing editor
Contact Lens Changes Color As It Releases Drugs
By Jerry Helzner, contributing editor
iStent Effective in Severe Glaucoma
By Jerry Helzner, contributing editor
Metrovision Launches Perimeter in US Market
By Jerry Helzner, contributing editor
Oculus Introduces Smartfield Perimeter
By Jerry Helzner, contributing editor
Bariatric Surgery Can Lower IOP
By Jerry Helzner, contributing editor
European Regulators Accept Rhopressa Application
By Jerry Helzner, contributing editor
Optometrists' Adherence to AAO Glaucoma Guidelines
By Jerry Helzner, contributing editor
Immune Cells May Play Role in Glaucoma Vision Loss
By Jerry Helzner, contributing editor
MIGS Drives Growth in Glaucoma Device Market
By Jerry Helzner, contributing editor
Aflibercept Reduces IOP in Neovascular Glaucoma Study
By Jerry Helzner, contributing editor
Topcon Gets Clearance for Laser Software
By Jerry Helzner, contributing editor